Cargando…
Gene delivery of a modified antibody to Aβ reduces progression of murine Alzheimer’s disease
Antibody therapies for Alzheimer’s Disease (AD) hold promise but have been limited by the inability of these proteins to migrate efficiently across the blood brain barrier (BBB). Central nervous system (CNS) gene transfer by vectors like adeno-associated virus (AAV) overcome this barrier by allowing...
Autores principales: | Elmer, Bradford M., Swanson, Kurt A., Bangari, Dinesh S., Piepenhagen, Peter A., Roberts, Errin, Taksir, Tatyana, Guo, Lei, Obinu, Maria-Carmen, Barneoud, Pascal, Ryan, Susan, Zhang, Bailin, Pradier, Laurent, Yang, Zhi-Yong, Nabel, Gary J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936806/ https://www.ncbi.nlm.nih.gov/pubmed/31887144 http://dx.doi.org/10.1371/journal.pone.0226245 |
Ejemplares similares
-
Glucosylceramide synthase inhibition reduces ganglioside GM3 accumulation, alleviates amyloid neuropathology, and stabilizes remote contextual memory in a mouse model of Alzheimer’s disease
por: Dodge, James C., et al.
Publicado: (2022) -
SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy
por: Delay-Goyet, Philippe, et al.
Publicado: (2016) -
Development of nonhuman adenoviruses as vaccine vectors
por: Bangari, Dinesh S., et al.
Publicado: (2006) -
Validation of memory assessment in the Starmaze task: Data from 14 month-old APPPS1 mice and controls
por: Schmitt, Julien, et al.
Publicado: (2021) -
Adenovirus receptors and their implications in gene delivery
por: Sharma, Anurag, et al.
Publicado: (2009)